European Institute of Oncology
2 clinical trials · 2 recruiting · OTHER
Trials by European Institute of Oncology
RECRUITINGNCT06328465
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
The aim of this study is to understand whether DWB-MRI (Diffusion Whole Body-Magnetic Resonance Imaging) is useful for early detection of locoregional or distant recurrence and...
Sponsor: European Institute of OncologyEnrolling: 1451 location
Invasive Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
RECRUITINGNCT07049133
Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
the anti-Human Epidermal Growth Factor Receptor 2 (HER2) Trastuzumab-Deruxtecan (T-DXd) has shown impressive clinical activity in pretreated patients with metastatic breast cancer...
Sponsor: European Institute of OncologyEnrolling: 841 location
Metastatic Breast Cancer